Arnold Susan Elizabeth 4
4 · PhaseBio Pharmaceuticals Inc · Filed Oct 5, 2020
Insider Transaction Report
Form 4
Arnold Susan Elizabeth
VP, Preclinical and Chem.
Transactions
- Exercise/Conversion
Common Stock
2020-10-01$1.15/sh+5,423$6,236→ 13,152 total - Exercise/Conversion
Common Stock
2020-02-27$1.15/sh+5,423$6,236→ 7,729 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-02-27$1.15/sh−5,423$6,236→ 0 totalExercise: $1.15From: 2014-03-01Exp: 2020-03-01→ Common Stock (5,423 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2020-10-01$1.15/sh−5,423$6,236→ 0 totalExercise: $1.15From: 2014-10-01Exp: 2020-10-01→ Common Stock (5,423 underlying)